We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Canadian Pacific Kansas City
CP
$79.2B
| $13.9M | 0.07% |
381,870
+358,405
| +1,527% | +$11.8M |
|
252
F5
FFIV
$23.5B
| $13.8M | 0.07% |
123,972
-19,436
| -14% | -$2.09M |
|
253
Halliburton
HAL
$27.1B
| $13.7M | 0.07% |
+193,341
| New | +$12.4M |
|
254
Intuitive Surgical
ISRG
$132B
| $13.3M | 0.07% |
291,492
+203,391
| +231% | +$8.97M |
|
255
Scotiabank
BNS
$108B
| $13.3M | 0.07% |
+212,948
| New | +$12.3M |
|
|
KOG
256
DELISTED
KODIAK OIL & GAS CORP
KOG
| $13.2M | 0.07% |
909,228
+604,066
| +198% | +$7.85M |
|
257
Banco Macro
BMA
$5.52B
| $13.1M | 0.07% |
364,664
+56,586
| +18% | +$1.81M |
|
|
AXIA
258
AXIA Energia
AXIA
$23.6B
| $13.1M | 0.07% |
5,643,673
+2,575,847
| +84% | +$6.55M |
|
|
ALU
259
DELISTED
Alcatel-Lucent
ALU
| $12.9M | 0.07% |
3,621,676
-9,275,636
| -72% | -$35.8M |
|
260
Chipotle Mexican Grill
CMG
$42.6B
| $12.9M | 0.07% |
1,086,400
-3,964,650
| -78% | -$42.9M |
|
261
Southwest Airlines
LUV
$23B
| $12.8M | 0.07% |
476,232
-150,833
| -24% | -$3.8M |
|
262
Alexandria Real Estate Equities
ARE
$8.4B
| $12.7M | 0.07% |
+163,976
| New | +$12.3M |
|
263
Aon
AON
$76.1B
| $12.7M | 0.07% |
141,165
+124,725
| +759% | +$10.8M |
|
|
KEG
264
DELISTED
KEY ENERGY SERVICES INC
KEG
| $12.7M | 0.07% |
1,387,875
+1,301,143
| +1,500% | +$11.9M |
|
|
WWAV
265
DELISTED
The WhiteWave Foods Company
WWAV
| $12.6M | 0.06% |
388,712
+291,597
| +300% | +$8.72M |
|
|
AAV
266
DELISTED
Advantage Oil & Gas Ltd
AAV
| $12.2M | 0.06% |
1,819,427
+1,396,534
| +330% | +$8.5M |
|
267
Lincoln National
LNC
$8.96B
| $12.2M | 0.06% |
236,274
-306,830
| -56% | -$15.2M |
|
268
Benchmark Electronics
BHE
$2.97B
| $12.1M | 0.06% |
473,834
+56,313
| +13% | +$1.32M |
|
|
AMSG
269
DELISTED
Amsurg Corp
AMSG
| $12M | 0.06% |
264,131
+28,754
| +12% | +$1.32M |
|
270
Super Micro Computer
SMCI
$19.1B
| $12M | 0.06% |
4,748,020
+120,520
| +3% | +$250K |
|
271
Globus Medical
GMED
$10.9B
| $12M | 0.06% |
500,232
+220,466
| +79% | +$5.32M |
|
|
CNL
272
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $11.8M | 0.06% |
200,100
+99,305
| +99% | +$5.17M |
|
|
CHU
273
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $11.8M | 0.06% |
769,252
-479,424
| -38% | -$7.04M |
|
|
ALXN
274
DELISTED
Alexion Pharmaceuticals
ALXN
| $11.8M | 0.06% |
75,467
+18,628
| +33% | +$2.94M |
|
275
Telecom Argentina
TEO
$5.94B
| $11.5M | 0.06% |
490,326
| – | – |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.